| Trial ID: | L5954 |
| Source ID: | NCT00572806
|
| Associated Drug: |
Insulin Aspart
|
| Title: |
Initiation of Insulin Aspart in Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: insulin aspart
|
| Outcome Measures: |
Primary: Blood glucose value, at 5 pm in a daytime blood glucose cycle profile | Secondary: Evaluation of 24-hour blood glucose cycle|HbA1c|Hypoglycaemic episodes
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
6
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2003-02-05
|
| Completion Date: |
2004-02-02
|
| Results First Posted: |
|
| Last Update Posted: |
2017-02-24
|
| Locations: |
Novo Nordisk Investigational Site, MONTPELLIER cedex 5, 34295, France
|
| URL: |
https://clinicaltrials.gov/show/NCT00572806
|
